Articles with public access mandates - Joshua M ShulmanLearn more
OverallNIHMRCWellcomeParkinson's UKHHMICIHRParkinson's Foundation, USANSFBMBFDoDDFGNIHRHelmholtzINSERMNWOAlzheimers's UKBBSRCCPRITDOEVAFWFRannisZonMwRCNANRMichael J Fox FoundationCanada First Research Excellence FundNHMRCFNRSDBTBHFCSODMTEuropean CommissionGovernment of SpainNMRCUK Research & InnovationLeducq Foundation, USA
Not available anywhere: 1
Structural variation and the expanding genomic architecture of Parkinson disease
JM Shulman
JAMA neurology 70 (11), 1355-1356, 2013
Mandates: US National Institutes of Health
Available somewhere: 67
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
Mandates: US National Institutes of Health, UK Medical Research Council, Parkinson's …
Parkinson's disease: genetics and pathogenesis
JM Shulman, PL De Jager, MB Feany
Annual Review of Pathology: Mechanisms of Disease 6 (1), 193-222, 2011
Mandates: US National Institutes of Health
Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
ECB Johnson, EB Dammer, DM Duong, L Ping, M Zhou, L Yin, ...
Nature medicine 26 (5), 769-780, 2020
Mandates: US Department of Energy, US National Institutes of Health, US Department of …
Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer’s disease risk factors in yeast
S Treusch, S Hamamichi, JL Goodman, KES Matlack, CY Chung, V Baru, ...
Science 334 (6060), 1241-1245, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer’s disease
C Cruchaga, JSK Kauwe, O Harari, SC Jin, Y Cai, CM Karch, BA Benitez, ...
Neuron 78 (2), 256-268, 2013
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ...
Brain 140 (12), 3191-3203, 2017
Mandates: US Department of Defense, US National Institutes of Health, Helmholtz …
Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms
C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R Von Coelln, ...
Movement Disorders 34 (6), 866-875, 2019
Mandates: US Department of Defense, US National Institutes of Health, German Research …
Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals
JJ Corneveaux, AJ Myers, AN Allen, JJ Pruzin, M Ramirez, A Engel, ...
Human molecular genetics 19 (16), 3295-3301, 2010
Mandates: US National Institutes of Health
Genetic architecture of subcortical brain structures in 38,851 individuals
CL Satizabal, HHH Adams, DP Hibar, CC White, MJ Knol, JL Stein, ...
Nature genetics 51 (11), 1624-1636, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
Common variants at 12q14 and 12q24 are associated with hippocampal volume
Nature genetics 44 (5), 545-551, 2012
Mandates: US National Institutes of Health, Austrian Science Fund, National Institute …
Tau activates transposable elements in Alzheimer’s disease
C Guo, HH Jeong, YC Hsieh, HU Klein, DA Bennett, PL De Jager, Z Liu, ...
Cell reports 23 (10), 2874-2880, 2018
Mandates: US National Science Foundation, US National Institutes of Health
A genome-wide association study of depressive symptoms
K Hek, A Demirkan, J Lahti, A Terracciano, A Teumer, MC Cornelis, ...
Biological psychiatry 73 (7), 667-678, 2013
Mandates: US National Institutes of Health, German Research Foundation, Wellcome Trust
Meta-analysis of the Alzheimer’s disease human brain transcriptome and functional dissection in mouse models
YW Wan, R Al-Ouran, CG Mangleburg, TM Perumal, TV Lee, K Allison, ...
Cell reports 32 (2), 2020
Mandates: US National Science Foundation, US National Institutes of Health, US …
Nigral pathology and parkinsonian signs in elders without Parkinson disease
AS Buchman, JM Shulman, S Nag, SE Leurgans, SE Arnold, MC Morris, ...
Annals of neurology 71 (2), 258-266, 2012
Mandates: US National Institutes of Health
CR1 is associated with amyloid plaque burden and age‐related cognitive decline
LB Chibnik, JM Shulman, SE Leurgans, JA Schneider, RS Wilson, D Tran, ...
Annals of neurology 69 (3), 560-569, 2011
Mandates: US National Institutes of Health, Parkinson's UK
A genome-wide scan for common variants affecting the rate of age-related cognitive decline
PL De Jager, JM Shulman, LB Chibnik, BT Keenan, T Raj, RS Wilson, ...
Neurobiology of aging 33 (5), 1017. e1-1017. e15, 2012
Mandates: US National Institutes of Health
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ...
Brain 143 (1), 234-248, 2020
Mandates: US National Institutes of Health, Alzheimers's UK, UK Medical Research …
Genome‐wide association study of the rate of cognitive decline in Alzheimer's disease
R Sherva, Y Tripodis, DA Bennett, LB Chibnik, PK Crane, PL de Jager, ...
Alzheimer's & Dementia 10 (1), 45-52, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Genetic susceptibility for Alzheimer disease neuritic plaque pathology
JM Shulman, K Chen, BT Keenan, LB Chibnik, A Fleisher, P Thiyyagura, ...
JAMA neurology 70 (9), 1150-1157, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program